Eledon Pharmaceuticals, Inc.
Data quality: 83%
ELDN
Nasdaq
Manufacturing
Chemicals
$3.12
▼
$0.01
(-0.32%)
Mkt Cap: 248.44 M
Price
$3.12
Mkt Cap
248.44 M
Day Range
$3.08 — $3.20
52-Week Range
$1.35 — $4.60
Volume
710,681
Open $3.09
50D / 200D Avg
$2.52
23.82% above
50D / 200D Avg
$2.57
21.45% above
Quick Summary
Key Takeaways
Negative free cash flow of -62.34 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-106.46%
Below sector avg (-51.02%)
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio6.74
Interest CoverageN/A
Valuation
PE (TTM)
-5.45
Below sector avg (-1.98)
P/B Ratio7.03
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -5.5 | -2.0 |
| P/B | 7.0 | 5.1 |
| ROE % | -106.5 | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
ETFs Holding This Stock
0.01% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -45.62 M |
| ROE | -106.46% | ROA | -33.20% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -62.34 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 6.74 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 82.01 M | Tangible Book Value | 35.36 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -5.45 | Forward P/E | N/A |
| P/B Ratio | 7.03 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -25.09% | ||
| Market Cap | 248.44 M | Enterprise Value | 244.77 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.52 | Revenue / Share | N/A |
| FCF / Share | -0.78 | OCF / Share | -0.78 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 136.66% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -45.62 M | -36.18 M | -40.33 M | -87.97 M | -34.51 M |
| EPS (Diluted) | -0.52 | -0.75 | -1.64 | -6.16 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | -43.00 M | -88.43 M | -36.87 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 66.27 M | 51.96 M | 30.31 M | 27.08 M | 23.74 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | 5,000.0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 35,000.0 | 431,000.0 | 0.0 | 0.0 | -2.35 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 169.01 M | 177.41 M | 89.07 M | 92.79 M | 170.55 M |
| Total Liabilities | 32.23 M | 59.27 M | 5.65 M | 8.61 M | 6.55 M |
| Shareholders' Equity | 81.09 M | 118.14 M | 83.42 M | 84.18 M | 164.00 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 22.81 M | 20.55 M | 4.61 M | 56.41 M | 84.83 M |
| Current Assets | 135.69 M | 143.73 M | 56.13 M | 59.52 M | 88.35 M |
| Current Liabilities | 18.34 M | 11.58 M | 3.90 M | 6.48 M | 4.40 M |
{"event":"ticker_viewed","properties":{"ticker":"ELDN","listing_kind":"stock","pathname":"/stocks/eldn","exchange":"Nasdaq","country":"US"}}